AMPLIFIED IMMUNO MODULATION INC. Trademark

Trademark Overview

On Thursday, August 22, 2019, a trademark application was filed for AMPLIFIED IMMUNO MODULATION INC. with the United States Patent and Trademark Office. The USPTO has given the AMPLIFIED IMMUNO MODULATION INC. trademark a serial number of 88588310. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, November 13, 2023. This trademark is owned by HEMISPHERX BIOPHARMA, INC.. The AMPLIFIED IMMUNO MODULATION INC. trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Intravenous solution for use in the treatment of viral infections, immune disorders, cancer and ME/CFS; intravenous solution for use in the treatment of viral infections, immune disorders, cancer and ME/CFS; intravenous solution for use in the treatment of injuries resulting from surgery, thermal accidents or burns; Interferons; Parenterally administered interferon for use in treating viral diseases, immunological disorders and cancer; Pharmaceutical products, namely, pharmaceutical preparations for treatment of viral and infectious diseases, cancer, immune disorders and ME/CFS; intranasal solutions for use as a vaccine adjuvant

Pharmaceutical research and development; Pharmaceutical research and development of drugs for the treatment of cancers, viral diseases, immunological disorders and ME/CFS
amplified immuno modulation inc.

General Information

Serial Number88588310
Word MarkAMPLIFIED IMMUNO MODULATION INC.
Filing DateThursday, August 22, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, November 13, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 18, 2020

Trademark Statements

Goods and ServicesIntravenous solution for use in the treatment of viral infections, immune disorders, cancer and ME/CFS; intravenous solution for use in the treatment of viral infections, immune disorders, cancer and ME/CFS; intravenous solution for use in the treatment of injuries resulting from surgery, thermal accidents or burns; Interferons; Parenterally administered interferon for use in treating viral diseases, immunological disorders and cancer; Pharmaceutical products, namely, pharmaceutical preparations for treatment of viral and infectious diseases, cancer, immune disorders and ME/CFS; intranasal solutions for use as a vaccine adjuvant
Disclaimer with Predetermined Text"IMMUNO MODULATION INC."
Goods and ServicesPharmaceutical research and development; Pharmaceutical research and development of drugs for the treatment of cancers, viral diseases, immunological disorders and ME/CFS

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, September 6, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, September 6, 2019
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAIM IMMUNOTECH INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressOCALA, FL 34473
Party NameAIM IMMUNOTECH INC.
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressOCALA, FL 34473
Party NameHEMISPHERX BIOPHARMA, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressOrlando, FL 32801

Trademark Events

Event DateEvent Description
Monday, November 13, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, November 13, 2023ABANDONMENT - NO USE STATEMENT FILED
Friday, April 21, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 20, 2023SOU EXTENSION 5 GRANTED
Thursday, April 13, 2023SOU EXTENSION 5 FILED
Thursday, April 20, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, April 13, 2023SOU TEAS EXTENSION RECEIVED
Saturday, October 15, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 13, 2022SOU EXTENSION 4 GRANTED
Thursday, October 13, 2022SOU EXTENSION 4 FILED
Thursday, October 13, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, April 6, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 4, 2022SOU EXTENSION 3 GRANTED
Monday, April 4, 2022SOU EXTENSION 3 FILED
Monday, April 4, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, January 18, 2022ASSIGNED TO EXAMINER
Friday, October 15, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 13, 2021SOU EXTENSION 2 GRANTED
Wednesday, October 13, 2021SOU EXTENSION 2 FILED
Wednesday, October 13, 2021SOU TEAS EXTENSION RECEIVED
Thursday, April 15, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 13, 2021SOU EXTENSION 1 GRANTED
Tuesday, April 13, 2021SOU EXTENSION 1 FILED
Tuesday, April 13, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, October 13, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 18, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 18, 2020PUBLISHED FOR OPPOSITION
Wednesday, July 29, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 28, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, July 15, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, July 14, 2020EXAMINER'S AMENDMENT ENTERED
Tuesday, July 14, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, July 14, 2020EXAMINERS AMENDMENT E-MAILED
Tuesday, July 14, 2020EXAMINERS AMENDMENT -WRITTEN
Tuesday, July 14, 2020ASSIGNED TO EXAMINER
Thursday, July 9, 2020PREVIOUS ALLOWANCE COUNT WITHDRAWN
Wednesday, July 8, 2020WITHDRAWN FROM PUB - OG REVIEW QUERY
Wednesday, July 8, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sunday, June 21, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, May 30, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, May 29, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, May 29, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, November 29, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, November 29, 2019NON-FINAL ACTION E-MAILED
Friday, November 29, 2019NON-FINAL ACTION WRITTEN
Friday, November 22, 2019ASSIGNED TO EXAMINER
Wednesday, October 9, 2019AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Friday, September 6, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, August 26, 2019NEW APPLICATION ENTERED

Related Keywords

modulation immuno amplified treatment disorders viral cancer pharmaceutical diseases immune solution intravenous immunological